Novartis Investigative Site

Dnipropetrovsk, Ukraine 49074

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. — Completed